Ticker
ATYRCompany Name
ATYR PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 101.53M | $ 12.68M | 12.49% |
3/31/2025 | $ 97.25M | $ 12.99M | 13.36% |
12/31/2024 | $ 96.83M | $ 13.28M | 13.72% |
9/30/2024 | $ 91.62M | $ 13.57M | 14.81% |
6/30/2024 | $ 105.94M | $ 13.85M | 13.07% |
3/31/2024 | $ 113.25M | $ 14.13M | 12.47% |
12/31/2023 | $ 120.65M | $ 15.1M | 12.51% |
9/30/2023 | $ 125.07M | $ 15.22M | 12.17% |
6/30/2023 | $ 132.75M | $ 15.39M | 11.59% |
3/31/2023 | $ 136.84M | $ 14.29M | 10.44% |
Debt / Assets
(=) Debt to Assets
Debt to Assets for ATYR PHARMA INC is calculated as follows: Debt [ $ 5.5M ] / Assets [ $ 41.64M ]
(=) Debt to Assets [ 13.21% ]
Minimum
Mar 31, 2022
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.33% |
median | 21.07% |
std | 24.52% |